Buy Coccidioidomycosis Medications Online
|
CoccidioidomycosisCoccidioidomycosis – General InformationCoccidioidomycosis, also known as San Joaquin Valley Fever or Valley Fever, is an infectious disorder caused by the breathing in of the spores of a fungus called Cocciodioides immitis. This type of fungus exists in the soil of certain arid areas of the southwestern United States, Mexico, and Central and South America. The Coccidioidomycosis disorder develops in two forms, primary and secondary. The primary form of the disease appears when a person inhales the windborne spores, and can vary in the severity of the symptoms. The first signs and symptoms of this form of the disease can be similar to the influenza disease or the common cold. The viral form of the disease, also called the secondary form, is considered more chronic, severe and progressive and is characterized by a granulomatous, which consists in a build up of nodular tissue caused by the inflammation, infection or any other injury. This form of the disease develops in the cutaneous and subcutaneous tissue, but there are cases in which the disease is present in the viscera, lungs and even central nervous system. In most of the cases, the disorder affects any type of patients, but the most vulnerable individuals are the pregnant female patients, due to their weakened immune system. Scientists say that the Coccidioidomycosis disorder is most severe in dark skinned patients. Generally, the disease is diagnosed by skin testing or serology, but when these are impossible to perform, there are several other procedures which can determine the disease. They include bronchoscopy, fine-needle biopsy, open-lung biopsy, pleural biopsy or skin biopsy.Coccidioidomycosis – SymptomsCoccidioidomycosis is caused by the inhalation of a fungus called Cocciodioides immitis, but there are cases in which the disease can develop from other conditions such as histoplasmosis, blastomycosis, paracoccidioidomycosis, several fungi, lung abscess, lymphoma, cough, fever or fatigue and old granuloma. In most of the cases the first signs and symptoms of Coccidioidomycosis can include cough, chest pain, which can vary from mild sensation of constriction to severe, fever, chills, night sweats, headache, muscle stiffness, muscle aches, joint stiffness, neck stiffness or shoulder stiffness rash, which can be painful, blood tinged sputum, loss of appetite, weight loss, wheezing excessive sweating, changes in mental status of the patient or sensitivity to light. There are cases in which other signs and symptoms of the disorder can also appear: joint swelling, joint pain, arthritis and ankle, feet, and leg swelling. To prevent this kind of fungal disease, a general maintenance of the good health is essential. If the patient experiences one of the signs or symptoms listed above, it is very important to consult with the health care provider as soon as possible. It is also important to start the treatment in an early stage of the disease, because if it is left untreated, the disease can become chronic, with painful manifestations or even lead to the death of the individual. In some cases the disease goes away by itself without any medical attention, but it is better to see a doctor (seek professional help).Coccidioidomycosis – TreatmentWhen dealing with Coccidioidomycosis, doctors recommend treatment trials with different drugs, usually antifungal drugs. The drugs are prescribed as amphotericin B, Fluconazole or Diflucan, ketoconazole or Vfend. Amphotericin B is an antifungal agent and has the effect of changing the membrane’s permeability by binding to sterols in the fungal cell membranes. Usually, the medicine is administered in 2.5 mg per day doses. Although the medicine is very effective in almost all the cases, it is safe to monitor the organism’s renal functions during the amphotericin B treatment. If the administration is stopped involuntarily, several conditions can develop. They include hypoxemia, acute dyspnea, and interstitial infiltrates. Fluconazole or Diflucan is an antifungal agent used to treat Coccidioidomycosis, which can be also prescribed as an inhibitor. Generally, the medicine is administered in 5 mg doses per day, depending on the stage of the disease. The purpose (aim) of this kind of medicine is usually to increase phenytoin concentrations, concentrations of theophylline, tolbutamide, glyburide, and glipizide, effects of anticoagulants and cyclosporine concentration. If the treatment with Fluconazole is interrupted, several conditions can develop which can include clinical hepatitis, cholestasis and fulminant hepatic failure including death or malignancy and while taking multiple concomitant medications. Ketoconazole is also an antifungal agent, and has the effect of impairing synthesis of ergosterol, leading to an increased permeability and leakage of cellular components. In most of the cases, the medicine is administered in 300 to 400 mg dose per day, and is contraindicated in fungal meningitis. Beside its benefic effects, the ketoconazole also decreases bioavailability and theophylline levels, and increases the effects of anticoagulants and cyclosporine. Another medicine used to treat Coccidioidomycosis is Itraconazole or Sporanox. It is used in combination with ketoconazole. The medicine is administered in 500 to 600 mg doses per day. It is not used as much as the other medicines because patients can easily develop drug allergies or liver dysfunction. It also has the effect of increasing tacrolimus and cyclosporine, plasma concentrations, digoxin levels, plasma levels of midazolam or triazolam. The medicine must be used with caution in patients suffering from hepatic insufficiency. Another treatment option for Coccidioidomycosis is Voriconazole or Vfend, which is antifungal agent. The effect of this medicine is to inhibit fungal cytochrome P450-mediated 14 alpha-lanosterol demethylation. It is usually administered in 200 mg doses per day. If the medicine is not administered correctly in patients suffering from hepatic dysfunction, it can lead to several conditions and side effects which can include visual disturbances, fever, rash, vomiting, nausea, diarrhea, headache, sepsis, peripheral edema, abdominal pain, rash, in rare cases, the Stevens-Johnson syndrome and phototoxicity, or respiratory disorders. There are cases in which the patient has developed a severe form of hepatotoxicity. Posaconazole or Noxafil is also considered effective in the Coccidioidomycosis disease. It is an antifungal agent administered in combination with Itraconazole. The main effect is the blocking of the ergosterol synthesis. |
|
![]() |
|
|
|
|
|